Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FCMWV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,780
Award facts
- Contract value 100% obligated
- $19,779.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19.8K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. The delivery order, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a straightforward pharmaceutical supply requirement with no set-aside designation applied. Entyvio (vedolizumab) is a biologic immunosuppressant used primarily to treat inflammatory bowel disease, making this delivery critical for supporting military healthcare facilities' pharmaceutical inventory and patient treatment needs.
This delivery order is issued under DMS Pharmaceutical Group's existing $500 million indefinite delivery contract with DLA under the SPE2DB program, which extends through November 2026. The SPE2DB vehicle enables DLA to procure a comprehensive range of pharmaceutical products, including branded and generic medications, biologics, and medical consumables, to support military health facilities globally. DMS Pharmaceutical Group's consistent award history with DLA and status as a woman-owned small business have positioned the company as a key supplier within the federal pharmaceutical supply chain, with this particular delivery order fulfilling specific medical supply requirements for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FCMWV?
SPE2DB25FCMWV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FCMWV worth?
The government has obligated $19,780 on SPE2DB25FCMWV.
Is contract SPE2DB25FCMWV an order under another contract?
Yes. SPE2DB25FCMWV is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMWV competed?
The extent of competition for SPE2DB25FCMWV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award